DrugCard
DrugCard is an AI-enabled tool that specializes in local literature screening for the pharmaceutical industry. It is designed to streamline drug safety routines...
Last verified:
What is DrugCard?
DrugCard is an AI-driven SaaS platform that automates medical literature screening, adverse event detection, and pharmacovigilance reporting to reduce manual workload and increase coverage. The platform continuously monitors thousands of journals (including 2,200+ local journals and coverage across 121+ countries) and supports over 100 languages to capture local-language safety information that typical workflows miss. Key features include automated literature monitoring, proprietary OCR for low-quality scanned pages, configurable keyword-based screening per product, instant email alerts and weekly summary reports, and structured evidence capture to support audits and regulatory inspections. DrugCard is designed for pharmaceutical companies, CROs, and pharmacovigilance teams who need scalable, auditable, and regulatory-compliant literature surveillance and signal detection while freeing PV specialists to focus on higher-value safety activities.
DrugCard pricing
Pricing model: Free
The website does not publish detailed public pricing; DrugCard offers trial access (examples mention a 14-day trial) and custom paid plans tailored per project, with pricing and time/cost-savings calculated individually for each customer. Paid plans are positioned to include continuous literature monitoring, language and journal coverage as configured, OCR processing, email alerts and weekly reports, and onboarding support (time to add journals typically 2–3 weeks; large custom journal packs may take longer). For exact plan tiers, seat counts, or enterprise licensing, the site asks interested organizations to contact sales for a proposal.
DrugCard pros
- AI-powered continuous literature monitoring across global journals
- Coverage of 100+ languages for local-language article screening
- Large local-journal coverage (2,200+ local journals monitored)
- Proprietary OCR delivering up to 99% accuracy on average scans
- Configurable keyword-based monitoring per drug/product
- Instant email alerts when new mentions are found
- Weekly summary reports prepared for audits and inspections
- Structured evidence capture for regulatory traceability
- Demonstrated 50–70% time savings vs manual screening
- Higher hit rates (3–5x more hits discovered vs manual)
- Designed to support CROs scaling PV projects
- Reduces repetitive tasks so specialists focus on signal detection
- Onboarding process for adding country-specific journal packs
- Audit- and compliance-focused feature set for GVP requirements
- Customer testimonial-backed reliability and productivity gains
- Scalable SaaS model suitable for multi-country surveillance
DrugCard cons
- Onboarding time can take 2–3 weeks to add new country journal packs
- Custom journal ingestion for large sets may take up to a month
- Full platform setup and tuning likely requires vendor engagement
- Some advanced customizations may need professional services
- Accuracy claims based on average scan quality may vary for poor scans
- Enterprise pricing details are not published publicly on-site
- Feature set focused on literature monitoring rather than full safety case management
- Potential integration work needed to connect with existing PV systems
- Dependence on keyword-definition quality for optimal recall
- Initial configuration may require pharmaco-safety expert input
Frequently asked questions about DrugCard
How many languages does DrugCard support?
DrugCard supports screening in over 100 languages, allowing customers to add search keywords in scripts ranging from Latin alphabets to non-Latin systems (for example Greek, Hindi, Arabic, Japanese hieroglyphics) so local-language journals can be monitored effectively.
How many journals and countries are monitored?
The platform monitors thousands of journals including over 2,200 local journals and coverage across 121+ countries, with the exact journal set configurable per customer and geography.
What accuracy does DrugCard achieve on scanned printed journals?
DrugCard uses proprietary OCR technology and reports up to 99% accuracy on average-quality scanned texts, while noting that extremely poor scan quality may reduce OCR performance and would be evaluated case-by-case.
How much time does DrugCard save compared to manual screening?
Based on customer feedback, DrugCard typically delivers 50–70% time savings for literature screening; an example on the site compares a manual 35-minute read-and-record task to 3 minutes with DrugCard for the same article screening workflow.
How quickly can new country journals be added?
Adding a new pack of journals generally takes about 2–3 weeks on average, though very large requests (for example 100 custom journals) have taken up to a month in reported cases; actual timelines depend on country complexity and volume.
Does DrugCard provide alerts and reports for found mentions?
Yes, DrugCard sends instant email notifications when a new drug mention is identified and also delivers weekly summary reports to simplify audit preparation and inspection evidence gathering.
Can DrugCard be used by CROs delivering PV services?
Yes, DrugCard is explicitly positioned for CROs to manage more pharmacovigilance projects and improve screening results, enabling CROs to meet their pharma clients' regulatory and quality expectations.
Is DrugCard compliant with pharmacovigilance regulatory requirements?
The platform is designed with auditability and regulatory compliance in mind (citing features like structured evidence capture and reporting for GVP-related inspections), though customers should validate specific regional compliance needs with the vendor during onboarding.
What is included in the trial?
The website references a 14-day trial offer (seen in public materials) intended to let prospective customers evaluate literature monitoring functionality; trial specifics such as scope of journal access or feature limits are provided by sales per request.
How does DrugCard compare to manual screening?
DrugCard claims several advantages over manual reading—higher hit discovery rates (3–5x), significant time savings (50–70%), and nearly complete keyword recognition for average-quality scans—while recommending custom assessment for each project to quantify expected gains.